Information:
Error:
ID
28420
Description
Study part: Investigator/ Site Information (Screening). A Phase III, Multicenter, Randomized, Double-Masked, Active Treatment-Controlled Study Of The Efficacy And Safety Of rhuFab V2 (Ranibizumab) Compared With Verteporfin (Visudyne®) Photodynamic Therapy In Subjects With Predominantly Classic Subfoveal Neovascular Age-Related Macular Degeneration
Keywords
Versions (1)
- 1/11/18 1/11/18 -
Copyright Holder
Roche
Uploaded on
January 11, 2018
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Investigator/ Site Information (Screening) rhuFab V2 Neovascular Age-Related Macular Degeneration FVF2587g
Investigator/ Site Information (Screening)
- StudyEvent: ODM
Similar models
Investigator/ Site Information (Screening)
- StudyEvent: ODM
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Subject Number
Item
Subject Number:
text
C2348585 (UMLS CUI [1])
Subject Initials
Item
Subject Initials:
text
C1997894 (UMLS CUI [1,1])
C2986440 (UMLS CUI [1,2])
C2986440 (UMLS CUI [1,2])
Date of report
Item
Report Date:
date
C1302584 (UMLS CUI [1])
Investigator Number
Item
Investigator Number:
text
C2826689 (UMLS CUI [1])
Site Number
Item
Site Number:
text
C2825164 (UMLS CUI [1,1])
C0237753 (UMLS CUI [1,2])
C0237753 (UMLS CUI [1,2])